Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole population pharmacokinetics and dose optimization in patients with liver dysfunction
ChiCTR1800015015Phase 4Recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of voriconazole in mycoses (2 arms), sponsored by The Second Xiangya Hospital. Primary endpoints: Blood concentration and Clinical index. Started Mar 2018; status: recruiting.
02
Drugs
voriconazole
03
Conditions
mycoses
Beyond the preview
Go deeper on ChiCTR1800015015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015015.